Table 2.
Distribution of the clinical manifestations among the DEC pathotypes
| Clinical data | EAEC (N = 31) | tEPEC (N = 19) | aEPEC (N = 11) | Co-infection (N = 5) |
p-value |
|---|---|---|---|---|---|
| Diarrhoea> 3/day | 1 (3.2%) | 4 (21%) | 11 (100%) | 2 (40%) | 0.05 |
| Diarrhoea> 5/day | 30 (96.7%) | 15 (78.9%) | 0 (0%) | 3 (60%) | 0.08 |
| Vomiting | 8 (25.8%) | 9 (47.3%) | 7 (63.6%) | 5 (100%) | 0.27 |
| Blood | 10 (32.2%) | 0 (0%) | 1 (9.1%) | 3 (60%) | 0.21 |
| Mucus | 23 (74.2%) | 19 (100%) | 11 (100%) | 5 (100%) | 0.88 |
| Hemolytic activity | 4 (12.9%) | 1 (5.2%) | 3 (27.2%) | 2 (40%) | 0.27 |
EAEC enteroaggregative E. coli, tEPEC typical enteropathogenic E. coli, aEPEC A typical enteropathogenic E. coli